Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (59)

2024

  1. Cognitive and brain connectivity trajectories in critically ill COVID-19 patients

    NeuroRehabilitation, Vol. 54, Núm. 3, pp. 359-371

  2. Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 885-893

  3. Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach

    Antibiotics, Vol. 13, Núm. 6

  4. The pupillary dilation reflex to a nociceptive stimulus as a tool for analgesia management: A diagnostic study

    Australian Critical Care, Vol. 37, Núm. 2, pp. 230-235

2023

  1. Ariketa fisikoa hirugarren adineko pertsonetan

    Osagaiz: osasun-zientzien aldizkaria, Vol. 7, Núm. 1, pp. 87-88

  2. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  3. Pupillary dilation reflex and behavioural pain scale: Study of diagnostic test

    Intensive and Critical Care Nursing, Vol. 74

  4. Sex Differences in Frailty Factors and Their Capacity to Identify Frailty in Older Adults Living in Long-Term Nursing Homes

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 1

2022

  1. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

2021

  1. Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents

    Scientific Reports, Vol. 11, Núm. 1

  2. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

  3. Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis

    Pharmaceutics, Vol. 13, Núm. 11

  4. Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies

    Pharmaceutics, Vol. 13, Núm. 7

  5. The nutritional status of long-term institutionalized older adults is associated with functional status, physical performance and activity, and frailty

    Nutrients, Vol. 13, Núm. 11

2020

  1. Brain connectivity and cognitive functioning in individuals six months after multiorgan failure

    NeuroImage: Clinical, Vol. 25

  2. Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective

    International Journal of Infectious Diseases, Vol. 93, pp. 329-338

  3. Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation

    Pharmaceutics, Vol. 12, Núm. 1

2019

  1. Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study

    The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 8, pp. 2289-2294

  2. Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis

    Annals of Intensive Care, Vol. 9, Núm. 1

  3. Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment

    Journal of Critical Care, Vol. 50, pp. 69-76